| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 164 | 2022 |
| Predictive value of the modified Early Warning Score in a Turkish emergency department E Armagan, Y Yilmaz, OF Olmez, G Simsek, CB Gul European Journal of Emergency Medicine 15 (6), 338-340, 2008 | 105 | 2008 |
| Urinary IL-18: a marker of contrast-induced nephropathy following percutaneous coronary intervention? CB Gul, M Gullulu, B Oral, A Aydinlar, O Oz, F Budak, Y Yilmaz, ... Clinical biochemistry 41 (7-8), 544-547, 2008 | 80 | 2008 |
| Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease Y Yilmaz, E Ulukaya, OO Gul, M Arabul, CB Gul, O Atug, AY Oral, S Aker, ... Clinical biochemistry 42 (9), 802-807, 2009 | 73 | 2009 |
| Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients OO Gul, E Tuncel, Y Yilmaz, E Ulukaya, CB Gul, S Kiyici, AY Oral, M Guclu, ... Metabolism 59 (1), 64-69, 2010 | 40 | 2010 |
| Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C. Y Yilmaz, E Dolar, E Ulukaya, S Akgoz, M Keskin, M Kiyici, O Yerci, ... Medical science monitor: international medical journal of experimental and …, 2009 | 37 | 2009 |
| Arterial elasticity and plasma levels of adiponectin and leptin in type 2 diabetic patients treated with thiazolidinediones O Oz, E Tuncel, S Eryilmaz, M Fazlioglu, CB Gul, C Ersoy, N Ocak, ... Endocrine 33, 101-105, 2008 | 27 | 2008 |
| The effect of hemodialysis, peritoneal dialysis and renal transplantation on nutritional status and serum micronutrient levels in patients with end-stage renal disease … OS Dizdar, A Yıldız, CB Gul, AI Gunal, A Ersoy, K Gundogan Journal of Trace Elements in Medicine and Biology 60, 126498, 2020 | 26 | 2020 |
| Comparative genotoxic and cytotoxic effects of the oral antidiabetic drugs sitagliptin, rosiglitazone, and pioglitazone in patients with type-2 diabetes: a cross-sectional … OO Gul, N Cinkilic, CB Gul, S Cander, O Vatan, C Ersoy, D Yılmaz, ... Mutation Research/Genetic Toxicology and Environmental Mutagenesis 757 (1 …, 2013 | 26 | 2013 |
| Epidemiological features of primary glomerular disease in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group A Turkmen, A Sumnu, E Cebeci, H Yazici, N Eren, N Seyahi, K Dilek, ... BMC nephrology 21, 1-11, 2020 | 25 | 2020 |
| Restless-legs syndrome and insomnia in hemodialysis patients D Yildiz, S Kahvecioğlu, N Buyukkoyuncu, AK Kilic, A Yildiz, CB Gul, ... Renal failure 38 (2), 194-197, 2016 | 21 | 2016 |
| Evaluation of serum S pondin 2 levels in the different stages of T ype 2 diabetic nephropathy S Kahvecioglu, M Guclu, Y Ustundag, CB Gul, I Dogan, T Dagel, B Esen, ... Nephrology 20 (10), 721-726, 2015 | 21 | 2015 |
| Helicobacter pylori: a role in schizophrenia? Y YilmazABEFG, CB GulEF, M ArabulEF, MA ErenEF Med Sci Monit 14 (7), 16, 2008 | 17 | 2008 |
| Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patients. M Arabul, M Gullulu, Y Yilmaz, MA Eren, B Baran, CB Gul, G Kocamaz, ... Medical science monitor: international medical journal of experimental and …, 2009 | 16 | 2009 |
| Relationship between glycemic control, microalbuminuria and cognitive functions in elderly type 2 diabetic patients CB Gul, O Oz Gul, S Cander, A Eroglu, M Hartavi, N Keni, A Bayindir, ... Renal Failure 36 (8), 1258-1262, 2014 | 14 | 2014 |
| Effect of the direct renin inhibitor aliskiren in the prevention of experimental contrast-induced nephropathy in the rat AE Kedrah, E Ari, Y Alahdab, CB Gul, B Macunluoglu, A Atakan, ... Kidney and blood pressure research 35 (6), 425-430, 2013 | 14 | 2013 |
| Ki-67 proliferation index in renal biopsy samples of patients with systemic lupus erythematosus and its correlation with clinical findings E Dalkilic, G Filiz, M Yavuz, K Dilek, A Ersoy, M Yurtkuran, A Oruç, CB Gul, ... Iranian journal of kidney diseases 7 (3), 198, 2013 | 14 | 2013 |
| Arterial dysfunction in early autosomal dominant polycystic kidney disease independent of fibroblast growth factor 23. A Yildiz, CB Gul, A Ersoy, B Asiltas, S Ermurat, S Dogan, K Karaağaç, ... Iranian journal of kidney diseases 8 (6), 2014 | 13 | 2014 |
| Cytokine signal suppressor (SOCS) 1-1478 CA/del gene polymorphism in Turkish patients with polycystic ovary syndrome O Oz Gul, S Cander, CB Gul, F Budak, B Oral, C Ersoy Journal of Obstetrics and Gynaecology 37 (7), 896-901, 2017 | 12 | 2017 |
| Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function CB Gul, A Yildiz, A Ersoy, S Kahvecioglu, B Asiltas, F Yildirim, S Ermurat, ... International urology and nephrology 47, 1187-1194, 2015 | 12 | 2015 |
Alparslan ErsoyUludag Universityuludag.edu.tr üzerinde doğrulanmış e-posta adresine sahip
